Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans.

Chamberland JP, Berman RL, Aronis KN, Mantzoros CS.

Eur J Endocrinol. 2013 Sep 13;169(4):453-62. doi: 10.1530/EJE-13-0098.

2.

Gender dimorphism and lack of day/night variation or effects of energy deprivation on undercarboxylated osteocalcin levels in humans.

Foo JP, Aronis KN, Chamberland JP, Thakkar B, Hamnvik OP, Brinkoetter M, Zaichenko L, Mantzoros CS.

Obesity (Silver Spring). 2013 Dec;21(12):E527-32. doi: 10.1002/oby.20453.

3.
4.

Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation.

Hamnvik OP, Thakkar B, Chamberland J, Aronis K, Schneider B, Mantzoros CS.

Int J Obes (Lond). 2015 Feb;39(2):260-4. doi: 10.1038/ijo.2014.106.

5.

Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults.

Aronis KN, Foo JP, Chamberland JP, Mantzoros CS.

J Clin Endocrinol Metab. 2012 Aug;97(8):2765-72. doi: 10.1210/jc.2012-1618.

6.

Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D.

Endocrinology. 2007 Oct;148(10):4687-94.

PMID:
17640997
7.

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.

Alfadda AA, Sallam RM, Chishti MA, Moustafa AS, Fatma S, Alomaim WS, Al-Naami MY, Bassas AF, Chrousos GP, Jo H.

Mol Cells. 2012 Jun;33(6):591-6. doi: 10.1007/s10059-012-0012-7.

8.

Chemerin gene expression is regulated by food restriction and food restriction-refeeding in rat adipose tissue but not in liver.

Stelmanska E, Sledzinski T, Turyn J, Presler M, Korczynska J, Swierczynski J.

Regul Pept. 2013 Feb 10;181:22-9. doi: 10.1016/j.regpep.2012.12.001.

PMID:
23328001
9.
10.

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.

Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M.

Metabolism. 2012 May;61(5):706-14. doi: 10.1016/j.metabol.2011.10.008.

PMID:
22136911
11.

Clinical aspects of leptin.

Sinha MK, Caro JF.

Vitam Horm. 1998;54:1-30. Review.

PMID:
9529971
12.

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease.

Döcke S, Lock JF, Birkenfeld AL, Hoppe S, Lieske S, Rieger A, Raschzok N, Sauer IM, Florian S, Osterhoff MA, Heller R, Herrmann K, Lindenmüller S, Horn P, Bauer M, Weickert MO, Neuhaus P, Stockmann M, Möhlig M, Pfeiffer AF, von Loeffelholz C.

Eur J Endocrinol. 2013 Oct 1;169(5):547-57. doi: 10.1530/EJE-13-0112.

13.

Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males.

Vamvini MT, Aronis KN, Chamberland JP, Mantzoros CS.

J Clin Endocrinol Metab. 2011 Nov;96(11):3416-23. doi: 10.1210/jc.2011-1665.

14.

The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects.

Sledzinski T, Korczynska J, Hallmann A, Kaska L, Proczko-Markuszewska M, Stefaniak T, Sledzinski M, Swierczynski J.

J Endocrinol Invest. 2013 Jun;36(6):428-34. doi: 10.3275/8770.

PMID:
23211604
15.

Insulin and metformin regulate circulating and adipose tissue chemerin.

Tan BK, Chen J, Farhatullah S, Adya R, Kaur J, Heutling D, Lewandowski KC, O'Hare JP, Lehnert H, Randeva HS.

Diabetes. 2009 Sep;58(9):1971-7. doi: 10.2337/db08-1528.

16.

Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet.

Becker M, Rabe K, Lebherz C, Zugwurst J, Göke B, Parhofer KG, Lehrke M, Broedl UC.

Diabetes. 2010 Nov;59(11):2898-903. doi: 10.2337/db10-0362.

17.

Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients.

Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Rotellar F, Valentí V, Silva C, Gil MJ, Salvador J, Frühbeck G.

Surg Obes Relat Dis. 2013 Mar-Apr;9(2):306-14. doi: 10.1016/j.soard.2011.11.001.

PMID:
22154272
18.

Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration.

Hwang JJ, Thakkar B, Chamberland JP, Mantzoros CS.

Metabolism. 2014 Jun;63(6):754-9. doi: 10.1016/j.metabol.2014.02.006.

PMID:
24703486
19.

Lack of Day/Night variation in fibroblast growth factor 21 levels in young healthy men.

Foo JP, Aronis KN, Chamberland JP, Mantzoros CS.

Int J Obes (Lond). 2015 Jun;39(6):945-8. doi: 10.1038/ijo.2014.215.

PMID:
25540981
20.

Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice.

Rourke JL, Muruganandan S, Dranse HJ, McMullen NM, Sinal CJ.

J Endocrinol. 2014 Aug;222(2):201-15. doi: 10.1530/JOE-14-0069.

Items per page

Supplemental Content

Support Center